Cancer presence associated with OR 1.88 for early mortality following coronary artery bypass graftingCancer presence linked to higher risks after heart bypass surgery

This meta-analysis evaluated the impact of cancer on clinical outcomes in patients undergoing coronary artery bypass grafting (CABG). The study included a large population of 99,866 patients to compare those with a history of cancer against those without. The primary objective was to determine if the presence of malignancy influenced early mortality and other common postoperative complications such as bleeding, infection, stroke, and acute kidney injury (AKI).

The analysis compared patients with a known diagnosis of cancer to a control group of patients without cancer. While specific dosing or surgical protocols were not detailed in this meta-analysis, the primary focus remained on the association between the underlying malignancy and postoperative outcomes. The study design aimed to provide a broad overview of how cancer status influences the perioperative period for cardiac surgery.

The primary outcome of early mortality showed a statistically significant increase in patients with cancer. The results reported an odds ratio (OR) of 1.88, with a 95% confidence interval (CI) of [1.004 to 3.520] and a p-value of 0.049. A sensitivity analysis further highlighted this risk; when the study excluding non-metastatic solid tumors was removed, the association became stronger, yielding an OR of 2.65 (95% CI [1.94 to 3.61]; p = 0.002).

Secondary outcomes provided mixed results regarding other complications. Bleeding was significantly higher in cancer patients, with an OR of 1.47 (95% CI [1.018 to 2.138]; p = 0.044). However, no statistically significant differences were observed for infection (OR 1.66; 95% CI [0.142 to 19.477]; p = 0.467), stroke (OR 0.85; 95% CI [0.463 to 1.563]; p = 0.370), or acute kidney injury (OR 1.08; 95% CI [0.755 to 1.545]; p = 0.545).

Safety and tolerability were assessed through these secondary outcomes. While bleeding was a confirmed risk, the high variability in infection data (due to a wide confidence interval) suggests that infection rates may not be consistently impacted by cancer status across different patient profiles. The lack of significant findings for stroke and AKI suggests these specific complications may be less influenced by malignancy than mortality or hemorrhage.

These results provide important context for managing high-risk surgical patients. While the meta-analysis identifies a clear association between cancer and increased early mortality, it also highlights that not all postoperative complications are equally affected by cancer status. The stronger association found in the sensitivity analysis suggests that the severity or stage of the malignancy may play a critical role in patient outcomes.

Methodological limitations include significant heterogeneity in the primary analysis (I2 = 87.6%), which can affect the precision of the pooled estimates. Furthermore, as this is a meta-analysis and not a prospective trial, the results are observational. Prospective validation is required to confirm these associations and to determine if specific cancer types or stages drive the observed risks.

Clinically, these findings suggest that patients with a history of cancer undergoing CABG may require heightened vigilance regarding early mortality and bleeding complications. The data suggests that while some complications like infection and stroke do not show significant differences in this analysis, the risk of death and hemorrhage is notably higher. Future research should focus on identifying which specific cancer characteristics lead to these increased risks to better tailor perioperative management.